KEMPHARM, INC·4

Aug 30, 5:09 PM ET

Mickle Travis C 4

4 · KEMPHARM, INC · Filed Aug 30, 2021

Insider Transaction Report

Form 4
Period: 2021-08-30
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2021-08-30$8.92/sh+5,000$44,60834,271 total
Holdings
  • Common Stock

    (indirect: By Trust)
    9,824
  • Common Stock

    (indirect: By LLC)
    1,034
  • Common Stock

    (indirect: By LLC)
    96,153
  • Common Stock

    (indirect: By Trust)
    15,242
Footnotes (2)
  • [F1]The Reporting Person is the sole manager member of Mickle Investments, LLC.
  • [F2]The Reporting Person is the sole manager member of Mickle Holdings, LLC.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4